Introduction
dyspnea
LONG COVID
According to the World Health Organization (WHO)Given these data, the National Institute of Statistics has estimated that approximately 10–20% of infected people developed persistent symptoms more than twelve weeks following infectionThe underlying etiology of Long COVID, as well as its duration and degree of severity, remain limited. The study by Taquet et al.It has been suggested that the management of Long COVID patients should be carried out and directed by general practitioners (GP)A recent systematic review has verified that TR can improve dyspnea, functionality, and physical components of quality of life in COVID-19 and Long COVID patientsDue to all of the above, due to the increasing use of TR programs, the lack of treatment for these patients and the experimental studies carried out in other territories, it has been considered opportune to design and create a mobile APP called ReCOVery that serves as a TR for Long COVID patients. This APP is based on clinical guidelines for the management of patients with Long COVID and the needs identified by affected patients. ReCOVery has content that rehabilitates in order to improve the quality of life and strengthen the personal constructs (health literacy, activation and self-efficacy) of these patients, through their own rehabilitation and empowerment.Hence, the main objective is to analyze the clinical efficacy of a TR through the ReCOVery APP, as compared to Treatment as Usual (TAU) for 3 months, administered in the Primary Health Care (PHC) context, as adjuvant treatment for individuals diagnosed with Long COVID. The second objective is to identify significant models associated with an improvement in the study variables.